Management and Economics
| Open Access | Engineering Optimization of a BFS Packaging Process for Pediatric Oral Rehydration Solutions: Impact on CAPEX, COGS, OEE, and Time to Market
Bekhzad Yuldashev , Strategic Operations Leader and Former CEO of Bayan Medical (Meros Pharm Group)" Windermere, FloridaAbstract
This study evaluates the engineering optimization of a Blow-Fill-Seal (BFS) production line at the Samarkand England Eco-Medical (SEEM) plant. Amidst the transformation of Uzbekistan’s pharmaceutical industry, the project focused on localizing the pediatric oral rehydration product REGIDREYD and expanding the line to include REGIDREYD ZINC. By reconfiguring a BFS line originally designed for intravenous (IV) fluids specifically removing the rubber cap assembly for a dedicated oral format the study assesses the impact on Overall Equipment Effectiveness (OEE), Capital Expenditure (CAPEX), and Cost of Goods Sold (COGS). Results indicate that reengineering existing assets achieved an OEE of over 81% and secured official state registration (DV/M 03775/03/21), while also enabling contract manufacturing for external brands such as REGIDOL.
Keywords
REGIDREYD, REGIDOL, Zinc, Blow-Fill-Seal, BFS, OEE, Samarkand England Eco-Medical, Uzbekistan, Pharmaceutical engineering.
References
UNICEF. (2016). One is too many: Ending child deaths from pneumonia and diarrhoea. Retrieved from https://data.unicef.org/resources/one-many-ending-child-deaths-pneumonia-diarrhoea/ (date accessed: August 15, 2018).
GBD 2016 Diarrhoeal Disease Collaborators. (2018). Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Infectious Diseases, 18(11), 1211–1228. https://doi.org/10.1016/S1473-3099(18)30362-1
Dhingra, U., Kisenge, R., Sudfeld, C. R., Dhingra, P., Somji, S., Dutta, A., Bhutta, Z. A., Dewey, K. G., Locks, L. M., Okronipa, H., & Fawzi, W. W. (2020). Lower-dose zinc for childhood diarrhea A randomized, multicenter trial. The New England Journal of Medicine, 383(13), 1231–1241. https://doi.org/10.1056/NEJMoa1915905
UNICEF Supply Division. (2021). Key supply and market dashboard: Oral rehydration salts (ORS) and zinc. Retrieved from: https://www.unicef.org/supply/media/22361/file/Key-supply-Market-Dashboard-February-2021.pdf (date accessed: January 19, 2021).
World Health Organization. (2017). WHO model list of essential medicines: 20th list (April 2017). Retrieved from: https://www.who.int/publications/i/item/eml-20 (date accessed: January 27, 2021).
UZPHARM-CONTROL. (2018). 74% of demand for medicines in Uzbekistan is covered by imported products. Retrieved from: https://www.uzpharm-control.uz/en/news/view/2018-02-06-medicines-in-Uzbekistan (date accessed: February 2, 2021).
President of the Republic of Uzbekistan. (2018). Medicines will become more accessible. Retrieved from: https://president.uz/en/1736 (date accessed: February 6, 2021).
President of the Republic of Uzbekistan. (2017). Decree of the President of the Republic of Uzbekistan No. UP-5229 dated November 7, 2017: On measures to radically improve the management system of the pharmaceutical industry. Retrieved from: https://lex.uz/en/docs/6943281 (date accessed: February 10, 2021).
President of the Republic of Uzbekistan. (2018). Decree of the President of the Republic of Uzbekistan No. UP-5460 dated June 20, 2018: On measures to increase the efficiency of state registration of medicines and improve the provision of them to the population. Retrieved from: https://lex.uz/en/docs/6973725 (date accessed: February 14, 2021).
UZPHARM-CONTROL. (2018). Good manufacturing practice (GMP) and good distribution practice (GDP). Retrieved from: https://www.uzpharm-control.uz/en/news/view/2018-10-18-GMP-GDP (date accessed: February 18, 2021).
UZPHARM-GXP. (2018). State standards of the Republic of Uzbekistan: O‘zDSt 2766:2018 GMP; O‘zDSt 2764:2018 GDP; O‘zDSt 2763:2018 GSP; O‘zDSt 2765:2018 GCP. Retrieved from: https://www.uzpharm-gxp.uz/en/documents/category/state-standards-of-the-republic-of-uzbekistan (date accessed: February 22, 2021).
Agency for the Development of the Pharmaceutical Industry under the Ministry of Health of the Republic of Uzbekistan. (2018). Pharmaceutical industry of Uzbekistan: Presentation materials. Retrieved from: https://www.bcci.bg/resources/files/uz-Bulgaria_final.pdf (date accessed: February 25, 2021).
U.S. Commercial Service. (2018). Uzbekistan 2018: Country commercial guide. Retrieved from: https://www.export-u.com/CCGs/Uzbekistan%20CCG%202018.pdf (date accessed: March 1, 2021).
Abdurakhmonov, J. U., & Voronina, O. M. (2017). Research of the pharmaceutical market of Uzbekistan and prospects of its development. In Topical Issues of New Drugs Development (Vol. 2, pp. 193–194). Retrieved from: https://dspace.nuph.edu.ua/bitstream/123456789/12528/3/%2B193-194.pdf (date accessed: March 3, 2021).
PETOŠEVIĆ. (2018). Uzbekistan amends medicine registration regulation. Retrieved from: https://www.petosevic.com/resources/news/2018/05/3911 (date accessed: March 5, 2021).
PETOŠEVIĆ. (2018). Uzbekistan simplifies approval of medicines registered in certain foreign countries. Retrieved from: https://www.petosevic.com/resources/news/2018/11/3987 (date accessed: March 7, 2021).
Cratia. (2018). Uzbekistan introduces a simplified medicines registration procedure. Retrieved from: https://cratia.com/en/news/v-uzbekistane-vvedena-uproshhennaya-proczedura-registraczii-lekarstv/ (date accessed: March 9, 2021).
Regapharm. (2018). Uzbekistan will recognize the registration of medicines from countries with high regulatory requirements. Retrieved from: https://regapharm.com/uzbekistan_will_recognize_the_registration_of_medicines_from_countries_with_high_regulatory_requirements (date accessed: March 11, 2021).
Hammer, C. (2018). Digitisation & Industry 4.0 in pharma production. ONdrugDelivery, (83), 81–83. Retrieved from: https://www.ondrugdelivery.com/wp-content/uploads/2018/02/ONdrugDel-PREFILLED-SYRINGES-83-Feb-2018-Dividella.pdf (date accessed: March 13, 2021).
Manzano, T. (2018). Getting ready for Pharma 4.0. ISPE Pharmaceutical Engineering. Retrieved from: https://www.ispe.gr.jp/ISPE/02_katsudou/pdf/201812_en.pdf (date accessed: March 15, 2021).
Ezell, S. (2018). Why manufacturing digitalization matters and how countries are supporting it. Information Technology and Innovation Foundation. Retrieved from: https://www2.itif.org/2018-manufacturing-digitalization.pdf (date accessed: March 17, 2021).
Lins, T., Rabelo, R. A., Correia, L. H. A., & Silva, J. S. (2018). Industry 4.0 retrofitting. In Proceedings of the 2018 VIII Brazilian Symposium on Computing Systems Engineering (SBESC). https://doi.org/10.1109/SBESC.2018.00011
Sachidananda, M., Leaver, J., & Kyratsis, Y. (2016). Discrete event simulation modelling for dynamic decision making in biopharmaceutical manufacturing. Procedia CIRP, 49, 35–40.
Ghafoorpoor Yazdi, P., Azizi, A., & Hashemipour, M. (2018). An empirical investigation of the relationship between overall equipment efficiency (OEE) and manufacturing sustainability in Industry 4.0 with time study approach. Sustainability, 10(9), Article 3031. https://doi.org/10.3390/su10093031
Tobe, A. Y., Widhiyanuriyawan, D., & Yuliati, L. (2017). The integration of overall equipment effectiveness (OEE) method and lean manufacturing concept to improve production performance (case study: Fertilizer producer). Journal of Engineering and Management in Industrial System, 5(2), 102–108. https://doi.org/10.21776/ub.jemis.2017.005.02.7
Ejsmont, K., & Lipiak, J. (2017). Evaluating effectiveness with regard to the implementation of the SMED method for a flexographic machine: A case study. In Proceedings of the 2017 International Conference on Management Science and Management Innovation (pp. 179–184). https://doi.org/10.2991/msmi-17.2017.40
Fam, S. F., Loh, S. L., Haslinda, M., Yanto, H., Khoo, L. M. S., & Yong, D. H. Y. (2018). Overall equipment efficiency (OEE) enhancement in manufacture of electronic components and boards industry through total productive maintenance practices. MATEC Web of Conferences, 150, Article 05037. https://doi.org/10.1051/matecconf/201815005037
Esmaeel, R. I., Haseeb, M., Sweis, R. J., & Alghizzawi, M. (2018). Fit manufacturing and overall equipment effectiveness: The mediating role on business performance. Procedia Manufacturing, 21, 699–706.
Tjoa, D. (2018). 2018: The evolution of pharmaceutical packaging. Contract Pharma. Retrieved from: https://www.contractpharma.com/2018-the-evolution-of-pharmaceutical-packaging/ (date accessed: March 19, 2021).
Voellmicke, C. (2018). A deep dive into pharma packaging moisture control. Packaging Strategies. Retrieved from: https://www.packagingstrategies.com/articles/90857-a-deep-dive-into-pharma-packaging-moisture-control (date accessed: March 21, 2021).
Lyashenko, V., Sotnik, S., & Baker, A. M. (2018). Features of packaging from polymers in pharmaceutics. Saudi Journal of Medical and Pharmaceutical Sciences, 4(2), 166–174. https://doi.org/10.21276/sjmps.2018.4.2.2
Raina, H., & Jindal, A. (2017). Packaging of non-injectable liquid pharmaceuticals: A review. Journal of Applied Pharmaceutical Science, 7(2), 248–257.
World Economic Forum. (2018). Readiness for the future of production report 2018. Retrieved from: https://www.weforum.org/publications/readiness-for-the-future-of-production-report-2018/ (date accessed: March 23, 2021).
Uzpharm-Control. (2021). State Register of Medicines: REGIDREYD (DV/M 03775/03/21). Retrieved from: https://uzpharm-control.uz/ (date accessed: March 25, 2021).
UNICEF Supply Division. (2021). Oral rehydration salts and zinc. Retrieved from: https://www.unicef.org/supply/oral-rehydration-salts-and-zinc (date accessed: March 27, 2021).
Hammer, C. (2018). Digitisation & industry 4.0 in pharma production. ONdrugDelivery Mag, 83, 81-83.
Download and View Statistics
Copyright License
Copyright (c) 2023 Bekhzad Yuldashev
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.